Exelixis Clinical Site #2

Nashville, Tennessee 37203

0 studies enrolling now · 1 studies all time

What they study most

Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors

Studies at this site

• Study of Zanzalintinib (XL092) + AB521 and Zanzalintinib + AB521 + Nivolumab in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Other Advanced Solid Tumors (STELLAR-009) — Stopped early